A genetic approach to the etiologic investigation of isolated intrauterine growth restriction

Published:August 02, 2021DOI:
      Intrauterine growth restriction (IUGR) affects 5% to 10% of pregnancies. Early diagnosis is important, because it enables the timely identification of the etiology. Clinically, the etiology may be categorized into maternal, fetal, or placental causes, however, there is considerable overlap in the pathogenesis. If adverse genetic defects can be excluded, pregnancies affected by IUGR can proceed with adequate monitoring of the fetal status to minimize risks for premature birth and intrauterine hypoxia.
      To read this article in full you will need to make a payment


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Monier I.
        • Receveur A.
        • Houfflin-Debarge V.
        • et al.
        Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study.
        Am J Obstet Gynecol. 2021; 29 (S0002-9378(21)00603-7)
      1. Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee Opinion No.682: Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology.
        Obstet Gynecol. 2016; 128: e262-e268
        • Del Gobbo G.F.
        • Yin Y.
        • Choufani S.
        • et al.
        Genomic imbalances in the placenta are associated with poor fetal growth.
        Mol Med. 2021; 27: 3
        • Bischoff F.Z.
        • Lewis D.E.
        • Simpson J.L.
        Cell-free fetal DNA in maternal blood: kinetics, source and structure.
        Hum Reprod Update. 2005; 11: 59-67

      Linked Article

      • Reply: Evidence to support offering chromosomal microarray analysis for isolated fetal growth restriction
        American Journal of Obstetrics & GynecologyVol. 225Issue 6
        • Preview
          We thank Li and colleagues for their interest in our work.1 In 2020, the Society for Maternal-Fetal Medicine recommended that prenatal chromosomal microarray analysis (CMA) be offered in cases of unexplained isolated fetal growth restriction (FGR).2 This grade 1C recommendation was mainly based on 1 meta-analysis of 9 observational studies; most studies were retrospective single-center studies, including <115 fetuses. However, based on the results from our study, Li and colleagues argued that we did not have enough evidence to conclude for offering CMA in cases of isolated FGR.
        • Full-Text
        • PDF